BioGaia
BioGaia is a Swedish healthcare company specializing in the development, marketing, and sale of probiotic products. The company operates through three main segments: the Paediatrics segment, which offers probiotic drops, gut health tablets, oral rehydration solutions, and cultures for use in licensed infant formula; the Adult Health segment, which includes gut health tablets, oral health lozenges, and cultures for licensed dairy products; and an Other segment that generates royalties from development projects and revenue from packaging solutions through its subsidiary CapAble. BioGaia's products aim to improve health across various demographics, with a strong focus on both pediatric and adult consumers. The company operates in multiple regions, enhancing its global presence in the probiotic market.
Boneprox
Seed Round in 2021
Boneprox AB is a Swedish company founded in 2013, based in Gothenburg, specializing in dental healthcare software. The company offers a range of tools designed to enhance the efficiency of dental practices and improve patient care. Its flagship product, Boneprox, analyzes bone quality and assesses the risk of osteoporosis. Additionally, ReferralExpress facilitates quick communication by allowing clinics to send and receive referrals to specialists efficiently. Another product, CBCT-Supervision, streamlines the cone beam computed tomography (CBCT) process within clinics. By leveraging advanced dental imaging and digital dentistry, Boneprox enables healthcare providers to securely exchange, analyze, and diagnose patient images, ultimately aiming to improve the accessibility of specialist care in various areas of dentistry.
MetaboGen
Acquisition in 2018
MetaboGen is a research and development company focused on biomarker identification and personalized treatment services. The company specializes in metagenomic data analysis, which it combines with development and clinical programs to enhance the understanding of bacterial strains related to specific health indications. By identifying and improving these bacterial strains, MetaboGen aims to support the probiotic industry in creating innovative diagnostic tests and therapeutic solutions.
MetaboGen
Corporate Round in 2018
MetaboGen is a research and development company focused on biomarker identification and personalized treatment services. The company specializes in metagenomic data analysis, which it combines with development and clinical programs to enhance the understanding of bacterial strains related to specific health indications. By identifying and improving these bacterial strains, MetaboGen aims to support the probiotic industry in creating innovative diagnostic tests and therapeutic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.